Logo image of DHCNI

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

NASDAQ:DHCNI - US25525P2065

16.86 USD
-0.05 (-0.3%)
Last: 8/27/2025, 9:49:10 AM
Fundamental Rating

2

DHCNI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHCNI have multiple concerns. DHCNI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DHCNI has reported negative net income.
DHCNI had a positive operating cash flow in the past year.
DHCNI had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

DHCNI has a worse Return On Assets (-6.03%) than 85.27% of its industry peers.
With a Return On Equity value of -15.46%, DHCNI is not doing good in the industry: 79.07% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

DHCNI's Gross Margin of 17.80% is on the low side compared to the rest of the industry. DHCNI is outperformed by 93.80% of its industry peers.
In the last couple of years the Gross Margin of DHCNI has declined.
DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHCNI has more shares outstanding
The number of shares outstanding for DHCNI has been increased compared to 5 years ago.
The debt/assets ratio for DHCNI is higher compared to a year ago.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that DHCNI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.34, DHCNI is doing worse than 61.24% of the companies in the same industry.
A Debt/Equity ratio of 1.42 is on the high side and indicates that DHCNI has dependencies on debt financing.
The Debt to Equity ratio of DHCNI (1.42) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACC6.93%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.37 indicates that DHCNI has no problem at all paying its short term obligations.
DHCNI has a Current ratio of 3.37. This is amongst the best in the industry. DHCNI outperforms 92.25% of its industry peers.
DHCNI has a Quick Ratio of 3.37. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.37, DHCNI belongs to the best of the industry, outperforming 92.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

DHCNI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.64%, which is quite impressive.
DHCNI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.29%.
DHCNI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%

3.2 Future

Based on estimates for the next years, DHCNI will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.22% on average per year.
Based on estimates for the next years, DHCNI will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y28.82%
EPS Next 2Y16.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.93%
Revenue Next 2Y3.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

DHCNI's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DHCNI is more expensive than 93.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.61
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

DHCNI's earnings are expected to grow with 16.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.22%
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.12%.
Compared to an average industry Dividend Yield of 6.31, DHCNI's dividend is way lower than its industry peers. On top of this 92.25% of the companies listed in the same industry pay a better dividend than DHCNI!
With a Dividend Yield of 1.12, DHCNI pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

The dividend of DHCNI decreases each year by -45.60%.
DHCNI has been paying a dividend for over 5 years, so it has already some track record.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.36%
EPS Next 2Y16.22%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (8/27/2025, 9:49:10 AM)

16.86

-0.05 (-0.3%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners77.81%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap4.07B
Analysts48
Price Target18.24 (8.19%)
Short Float %0%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-3.36%
Div Incr Years0
Div Non Decr Years3
Ex-Date07-15 2025-07-15 (0.3515625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.74%
Min EPS beat(2)-71.02%
Max EPS beat(2)122.5%
EPS beat(4)2
Avg EPS beat(4)34.05%
Min EPS beat(4)-71.02%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)16.12%
EPS beat(12)4
Avg EPS beat(12)5.38%
EPS beat(16)4
Avg EPS beat(16)-11.59%
Revenue beat(2)0
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)-0.04%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)4
Avg Revenue beat(16)-1.01%
PT rev (1m)13.32%
PT rev (3m)-10.8%
EPS NQ rev (1m)-2.5%
EPS NQ rev (3m)6.82%
EPS NY rev (1m)-14.73%
EPS NY rev (3m)-19.35%
Revenue NQ rev (1m)0.97%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.67
P/FCF N/A
P/OCF 45.68
P/B 2.19
P/tB 2.19
EV/EBITDA 27.61
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)0.37
OCFY2.19%
SpS6.31
BVpS7.68
TBVpS7.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.8%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 11.07
Cap/Depr 66.82%
Cap/Sales 12.33%
Interest Coverage N/A
Cash Conversion 37.41%
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 0.34
F-Score6
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
EPS Next Y28.82%
EPS Next 2Y16.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%
Revenue Next Year3.93%
Revenue Next 2Y3.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year374.57%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y71.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.65%
OCF growth 3YN/A
OCF growth 5Y-15.84%